Lido Advisors’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
Other funds holding IMNM
Lido Advisors's IMNM Position: Q3 2026 in Review
Lido Advisors increased its Immunome (IMNM) stake by 0.1% in Q3 2026, buying an estimated $1.27K and bringing the position to 49,392 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1053.
Lido Advisors first reported a position in IMNM in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.07M in Q1 2026. 211 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.
- Lido Advisors held 49,392 shares of Immunome worth $1.06M as of Q3 2026.
- Lido Advisors bought 51 Immunome shares in Q3 2026, an estimated $1.27K.
- Immunome made up ﹤0.01% of Lido Advisors's portfolio in Q3 2026, its #1053 holding.
- Lido Advisors first reported a position in Immunome in Q1 2025 and has held it in 7 quarters since.
- Lido Advisors's Immunome position peaked at $1.07M in Q1 2026.
- 211 funds tracked by Wall St. Rank held Immunome as of Q3 2026.
Based on Lido Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.